Analysts' Actions: AMZN, MDRX, EXPE, JBLU

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Amazon.com (AMZN) was upgraded to Buy at Nomura. $285 price target. Company can continue to expand margins.

Amazon.com (AMZN) was upgraded to Buy at Bank of America/Merrill Lynch. $270 price target. Sales have stabilized and margins are improving.

Air Products and Chemicals (APD) was downgraded to Neutral from Buy at Citigroup. $95 price target. Merchant challenges continue.

Celanese Corp. (CE) was upgraded to Buy from Neutral at Citigroup. $56 price target. Weakness in acetyls chain is now reflected in stock price.

CH Robinson (CHRW) was upgraded from Sell to Hold at Stifel Nicolaus. Valuation call.

Community Partners Bancorp (CPBC) was upgraded to Buy at TheStreet Ratings.

Deckers Outdoor (DECK) downgraded to Hold from Buy at Jefferies. $65 price target. Loss of confidence in near-term EPS visibility.

Deckers Outdoor (DECK) was downgraded from Buy to Hold at Auriga USA. $65 price target. Closeout trends for UGG and Teva were disappointing.

Deckers Outdoor Corp. (DECK) was downgraded to Hold at TheStreet Ratings.

Expedia (EXPE) was upgraded from Underweight to Neutral at JP Morgan. $37 price target. Bookings are growing and the company is buying back more stock.

First Energy (FE) was upgraded to Buy at TheStreet Ratings.

Green Dot (GDOT) was downgraded from Buy to Neutral at Compass Point said. $30 price target. Company is in a transitional period and lacks near-term visibility.

Idacorp (IDA) was upgraded from Market Perform to Outperform, Wells Fargo said. Company trades at a discount to its peers.

Jetblue (JBLU) was upgraded to Hold from Sell, Dahlman Rose said. Valuation call.

Las Vegas Sands (LVS) was initiated with an In-Line rating, Imperial Capital said. Valuation call, based on $62 price target.

Allscripts (MDRX) was downgraded from Outperform to Neutral, Credit Suisse said. $8 price target. Company is facing higher integration challenges.

Allscripts (MDRX) was downgraded to Neutral from Buy at UBS. $10 price target. Bookings, revenue and EPS all miss.

Allscripts (MDRX) was downgraded to Hold from Buy at Jefferies said. $10.50 price target. Poor operating results and weak bookings.

Allscripts (MDRX) was downgraded to Market Perform at William Blair. Company is currently in disarray.

Allscripts (MDRX) was downgraded from Overweight to Neutral at Piper Jaffray said. $11 price target. Company cut guidance and lost several executives.

MetroPCS (PCS) was downgraded from Outperform to Market Perform at Wells Fargo. Company lacks near-term catalysts.

MetroPCS (PCS) was downgraded to Hold at Canaccord Genuity. $9 price target. Company cut its guidance once again.

MetroPCS (PCS) was downgraded to Hold at Detusche Bank said. $9 price target. Company will likely lose net subscribers until the fourth quarter.

Safeway (SWY) was downgraded to Hold at TheStreet Ratings.

Silicon Laboratories (SLAB) was upgraded to Buy from Neutral at Citigroup. $43 price target. Unexpected Touch exit and CEO transition drive selloff and create attractive entry point.

Silicon Laboratories (SLAB) upgraded from Neutral to Buy at Miller Tabak. $43 price target. Stock sold off, even though the company gave solid guidance.

Seagate (STX) was downgraded to Neutral at Bank of America/Merrill Lynch. $32 price target. Estimates also cut, as industry pricing will likely become more competitive.

Seagate (STX) was downgraded from Buy to Hold at Craig-Hallum. $37 price target. Industry supply has caught up to demand.

Valero (VLO) was initiated with a Buy rating at Dahlman Rose. $33 price target. Stock can continue to move higher if the company delivers on plan.

Western Digital (WDC) was downgraded to Neutral at Bank of America/Merrill Lynch. $46 price target. The company cut its forward guidance as customers are becoming more sensitive to price.

Western Digital (WDC) was downgraded from Buy to Hold at Craig-Hallum. $37 price target. Industry supply has caught up with demand.

VCA Antech (WOOF) was upgraded to Buy at TheStreet Ratings.

Wynn Resorts (WYNN) was started with an Outperform rating, Imperial Capital said. $151 price target. Valuation call, as the company trades at a discount to its peers.

Zynga (ZNGA) was upgraded from Neutral to Overweight at JP Morgan. $14 price target. Company is seeing strong user growth and mobile is gaining traction.

Zynga (ZNGA) was upgraded to Neutral at Bank of America/Merrill Lynch said. $10 price target. Estimates also boosted, as mobile is driving growth.

STOCK COMMENTS / EPS CHANGES

American Eagle Outfitters (AEO) numbers raised at Oppenheimer. Shares of AEO now seen reaching $24, Oppenheimer said. Estimates also raised on encouraging recent trends. Outperform rating.

Amazon.com (AMZN) target raised at Oppenheimer. Shares of AMZN now seen reaching $250, Oppenheimer said. Gross sales per customer rebounding to double-digits. Outperform rating.

Amazon.com (AMZN) target raised at Citigroup. Shares of AMZN now seen reaching $275, Citigroup said. High ened revenue results and arguably bullish Q2 revenue guidance. Buy rating.

Bunge (BG) estimates were cut through 2013 at Credit Suisse. Company is seeing weakness in sugar. Outperform rating and new $78 price target.

Celgene (CELG) numbers lowered at UBS. Shares of CELG now seen reaching $85, UBS said. Estimates also lowered to reflect pricing and collection headwinds. Buy rating.

CME Group (CME) numbers cut at UBS. Shares of CME now seen reaching $300, UBS said. Estimates also lowered on weak near term volumes. Buy rating.

Consol Energy (CNX) numbers lowered at Credit Suisse. Shares of CNX now seen reaching $38, according to Credit Suisse. Estimates also cut, as coal demand continues to be hurt by lower natural gas prices. Neutral rating.

Equifax (EFX) estimates, target raised at Credit Suisse. Shares of EFX now seen reaching $49, according to Credit Suisse. Estimates also increased, given the company's new guidance. Neutral rating.

Fidelity National (FIS) estimates were boosted through 2014 at Credit Suisse. Company is realizing higher sales. Neutral rating and new $36 price target.

Gilead Sciences (GILD) target raised at Citigroup. GILD target increased to $64, Citigroup said. Recent positive data in HCV. Buy rating.

GNC (GNC) estimates, target raised at Morgan Stanley. Shares of GNC now seen reaching $47, according to Morgan Stanley. Estimates also increased, as new products are driving growth. Overweight rating.

KBR (KBR) estimates, target reduced at Credit Suisse. Shares of KBR now seen reaching $47, according to Credit Suisse. Estimates also cut, as some projects have been delayed. Outperform rating.

KBR (KBR) numbers lowered at UBS. Shares of KBR now seen reaching $43, UBS said. Estimates also lowered on near term uncertainty. Buy rating.

Mead Johnson (MJN) estimates were raised through 2014 at Morgan Stanley. Asia and Latin America are driving growth. Overweight rating and new $90 price target.

Maxim Integrated (MXIM) numbers boosted at Credit Suisse. Shares of MXIM now seen reaching $34, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins. Outperform rating.

O'Reilly Automotive (ORLY) numbers boosted at Morgan Stanley. Shares of ORLY now seen reaching $110, according to Morgan Stanley. Estimates also upped, as the company is realizing higher margins. Overweight rating.

Occidental Petroleum (OXY) estimates lowered at UBS. OXY estimates lowered through 2013, UBS said. Wider differentials and higher costs. Buy rating and $113 price target.

MetroPCS (PCS) numbers cut at UBS. Shares of PCS now seen reaching $7.50, UBS said. Estimates also lowered on costs of 4G transition. Neutral rating.

Starbucks (SBUX) estimates lowered at UBS. SBUX estimates lowered through 2013, UBS said. Lower profit from Europe and higher reinvestment. Buy rating and $61 price target.

SolarWinds (SWI) estimates, target upped at Morgan Stanley. SWI estimates were boosted through 2013, Morgan Stanley said. Both new and existing products are growing well. Underweight rating and new $39 price target.

Skyworks Solutions (SWKS) numbers raised at Oppenheimer. Shares of SWKS now seen reaching $32, Oppenheimer said. Estimates also raised on better than expected quarter.

Wabco (WBC) estimates, target increased at Credit Suisse. WBC estimates were raised through 2014, Credit Suisse said. The company boosted guidance. Outperform rating and new $77 price target.

Waste Management (WM) numbers cut at JP Morgan. Shares of WM now seen reaching $35, according to JP Morgan. Estimates also reduced, given the company's new guidance. Neutral rating.

>To submit a news tip, email: [e-mail].

READERS ALSO LIKE:

>>WellPoint, Credit Suisse Earnings; 'Super Mario' Sequel: Hot Trends

>>US Airways Beats Estimates, Sees Strong Demand

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.